GLP1R and heart failure: For example, Sardu et al. [24] found that treatment with GLP-1 RA over 12 months resulted in improvements in all measured cardiac dimensions, alongside a decrease in arrhythmic events and heart failure hospitalizations, highlighting the potential of this treatment in enhancing cardiac outcomes.